News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,892 Results
Type
Article (40426)
Company Profile (187)
Press Release (671279)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (209479)
Career Advice (1931)
Deals (35043)
Drug Delivery (109)
Drug Development (79482)
Employer Resources (152)
FDA (15916)
Job Trends (15316)
News (347762)
Policy (32838)
Tag
Academia (2740)
Accelerated approval (6)
Adcomms (22)
Allergies (95)
Alliances (46274)
ALS (102)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (152)
Approvals (15896)
Artificial intelligence (303)
Autoimmune disease (29)
Automation (16)
Bankruptcy (331)
Best Places to Work (12326)
BIOSECURE Act (22)
Biosimilars (117)
Biotechnology (135)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (308)
Cancer (2459)
Cardiovascular disease (208)
Career advice (1562)
Career pathing (23)
CAR-T (168)
Cell therapy (487)
Cervical cancer (22)
Clinical research (64841)
Collaboration (921)
Company closure (2)
Compensation (575)
Complete response letters (29)
COVID-19 (2403)
CRISPR (46)
C-suite (275)
Cystic fibrosis (107)
Data (2350)
Decentralized trials (2)
Denatured (20)
Depression (55)
Diabetes (294)
Diagnostics (6817)
Digital health (20)
Diversity (4)
Diversity, equity & inclusion (39)
Drug discovery (138)
Drug pricing (109)
Drug shortages (28)
Duchenne muscular dystrophy (104)
Earnings (96022)
Editorial (40)
Employer branding (21)
Employer resources (121)
Events (124512)
Executive appointments (784)
FDA (17315)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (816)
Gene editing (119)
Generative AI (27)
Gene therapy (353)
GLP-1 (797)
Government (4835)
Grass and pollen (6)
Guidances (130)
Healthcare (20622)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (145)
Indications (30)
Infectious disease (2566)
Inflammatory bowel disease (158)
Inflation Reduction Act (8)
Influenza (58)
Intellectual property (102)
Interviews (326)
IPO (17084)
IRA (43)
Job creations (3418)
Job search strategy (1375)
Kidney cancer (11)
Labor market (46)
Layoffs (523)
Leadership (8)
Legal (7700)
Liver cancer (81)
Lung cancer (344)
Lymphoma (160)
Machine learning (7)
Management (43)
Manufacturing (350)
MASH (74)
Medical device (14392)
Medtech (14397)
Mergers & acquisitions (18603)
Metabolic disorders (768)
Multiple sclerosis (89)
NASH (20)
Neurodegenerative disease (107)
Neuropsychiatric disorders (32)
Neuroscience (2046)
NextGen: Class of 2025 (7089)
Non-profit (5018)
Now hiring (27)
Obesity (413)
Opinion (215)
Ovarian cancer (81)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (161)
Partnered (17)
Patents (256)
Patient recruitment (119)
Peanut (51)
People (56676)
Pharmaceutical (48)
Pharmacy benefit managers (18)
Phase I (20254)
Phase II (28727)
Phase III (21554)
Pipeline (1354)
Policy (150)
Postmarket research (2195)
Preclinical (8522)
Press Release (71)
Prostate cancer (113)
Psychedelics (35)
Radiopharmaceuticals (267)
Rare diseases (422)
Real estate (5726)
Recruiting (57)
Regulatory (22553)
Reports (49)
Research institute (2443)
Resumes & cover letters (339)
Rett syndrome (5)
RNA editing (3)
RSV (50)
Schizophrenia (79)
Series A (142)
Series B (94)
Service/supplier (9)
Sickle cell disease (57)
Special edition (19)
Spinal muscular atrophy (154)
Sponsored (25)
Startups (3330)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (40)
The Weekly (51)
Vaccines (707)
Venture capitalists (43)
Weight loss (282)
Women's health (31)
Worklife (13)
Date
Today (225)
Last 7 days (946)
Last 30 days (3190)
Last 365 days (34742)
2025 (12500)
2024 (37313)
2023 (42382)
2022 (53016)
2021 (57342)
2020 (56695)
2019 (50584)
2018 (37410)
2017 (33678)
2016 (33120)
2015 (38525)
2014 (31629)
2013 (26798)
2012 (28035)
2011 (28758)
2010 (25653)
Location
Africa (731)
Alabama (59)
Alaska (7)
Arizona (197)
Arkansas (14)
Asia (42219)
Australia (6916)
California (6483)
Canada (2089)
China (565)
Colorado (283)
Connecticut (297)
Delaware (161)
Europe (94492)
Florida (965)
Georgia (222)
Idaho (59)
Illinois (587)
India (28)
Indiana (335)
Iowa (10)
Japan (176)
Kansas (103)
Kentucky (26)
Louisiana (12)
Maine (70)
Maryland (973)
Massachusetts (4951)
Michigan (246)
Minnesota (420)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (25)
Nevada (69)
New Hampshire (69)
New Jersey (1846)
New Mexico (31)
New York (1841)
North Carolina (1095)
North Dakota (9)
Northern California (2852)
Ohio (222)
Oklahoma (15)
Oregon (38)
Pennsylvania (1438)
Puerto Rico (14)
Rhode Island (32)
South America (1127)
South Carolina (26)
South Dakota (1)
Southern California (2454)
Tennessee (106)
Texas (964)
United States (24752)
Utah (197)
Virginia (161)
Washington D.C. (64)
Washington State (587)
West Virginia (3)
Wisconsin (63)
711,892 Results for "20".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
VC Financings Drop 20% in Q1 but Megarounds Keep Median Deal Size High
Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first three months of this year, headlined by a clutch of massive funding rounds.
May 6, 2025
·
2 min read
·
Annalee Armstrong
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Enpro to Present at Oppenheimer 20th Annual Industrial Growth Conference
May 1, 2025
·
1 min read
Weight Loss
‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss
With Amgen’s MariTide results at the lower end of investors’ expectation of 20% to 25% weight loss, the much-anticipated readout sent the company’s shares tumbling.
November 26, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Synthetic Design Lab Emerges with $20M to Advance Next-Generation ADCs
April 24, 2025
·
5 min read
Press Releases
Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering
April 15, 2025
·
6 min read
Press Releases
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
April 30, 2025
·
5 min read
Press Releases
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
March 31, 2025
·
3 min read
Press Releases
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
April 30, 2025
·
3 min read
Business
Seaport, With 20/20 Hindsight, Takes Lessons From Neuropsych’s Stumbles
Amidst a “renaissance” of interest in neuropsychiatry, Seaport’s executive team is taking nothing for granted.
January 15, 2025
·
5 min read
·
Annalee Armstrong
1 of 71,190
Next
